日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

INDUCE-3:一项随机 II/III 期研究,评估一线 Feladilimab 联合 Pembrolizumab 治疗复发/转移性头颈部鳞状细胞癌患者的疗效

Rischin, Danny; Hansen, Aaron R; Cohen, Ezra E W; Tahara, Makoto; Harrington, Kevin J; Haddad, Robert I; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J; Washburn, Michael L; Phillips-Jones, Amy; Russell, John; Roy-Ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe

Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies

Fianlimab(一种人淋巴细胞活化基因-3单克隆抗体)联合cemiplimab:晚期恶性肿瘤的肿瘤特异性扩展队列研究

Kim, Tae Min; Williamson, Stephen K; Papadopoulos, Kyriakos P; Hamid, Omid; Dy, Grace K; McDermott, Ray; Birnbaum, Ariel; Kaczmar, John M; Lakhani, Nehal; Rischin, Danny; Sarker, Debashis; Dowlati, Afshin; Zhu, Xin-Hua; Malhotra, Jyoti; Pouliot, Jean-Francois; Mani, Jayakumar; Brennan, Laura; Fang, Fang; Chen, Shuquan; Salvati, Mark; Lowy, Israel; Khaled, Ahmed; Lewis, Karl D; Kroog, Glenn; Fury, Matthew G; Cho, Byoung Chul

Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity

DB-020鼓室内注射降低高剂量顺铂耳毒性的随机Ib期临床试验

Panizza, Benedict J; O'Leary, Stephen John; Hart, Christopher David; Diwakarla, Chandra Sai; Barnett, Catherine; Lapuerta, Pablo; Lee, John; Raines, Shane; Quigley, Tera; Wolff, Heather M; Keilty, John; Ladwa, Rahul; Porceddu, Sandro V; McGrath, Margaret; Seetharamu, Nagashree; Fua, Tsien; Rischin, Danny

First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors

ICOS激动剂feladilimab治疗晚期实体瘤患者的首次人体I期研究

Maio, Michele; Moreno, Victor; Martin-Liberal, Juan; Opdam, Frans; Hansen, Aaron; Bauer, Todd M; Le Tourneau, Christophe; Italiano, Antoine; Rischin, Danny; Ellis, Catherine; Turner, David; Yadavilli, Sapna; Zhou, Helen; Hirschfeld, Steven; Ballas, Marc; Diaz-Padilla, Ivan; Angevin, Eric

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

INTERLINK-1:一项评估莫那珠单抗联合西妥昔单抗治疗复发/转移性头颈部鳞状细胞癌的III期随机、安慰剂对照研究

Fayette, Jérôme; Licitra, Lisa; Harrington, Kevin; Haddad, Robert; Siu, Lillian L; Liu, Yi-Chun; Tahara, Makoto; Machiels, Jean-Pascal; Rischin, Danny; Seiwert, Tanguy Y; Ferris, Robert L; Keilholz, Ulrich; Psyrri, Amanda; Keam, Bhumsuk; Bossi, Paolo; Metcalf, Robert; Hsieh, Ching-Yun; Clement, Paul M J; Isaev, Pavel; Mudunov, Ali; Dinis, José; Hoeben, Ann; Kasper, Stefan; Klinghammer, Konrad; Hwang, Michael; Blando, Jorge; Serrano, Olivier; Ruscica, Dario; Cohen, Roger B

Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancer

对于癌症成年患者而言,在家中接受静脉抗癌治疗与在医院或社区接受治疗的比较

Grobler, Liesl; O'Connor, Denise; Rischin, Danny; Putrik, Polina; Karnon, Jonathan; Rischin, Kobi J; McKenzie, Bayden J; Ben Ami, Noa; Whale, Rhiannon; Buchbinder, Rachelle

Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II-IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial

在皮肤鳞状细胞癌深度测序(DISCERN)试验中,新辅助西米普利单抗治疗II-IV期皮肤鳞状细胞癌的放射学、病理学和手术结果

Lim, Annette M; Baker, Benjamin; Lion, Peter; Angel, Christopher M; Simmons, Jennifer; Jackson, Bryce; Magarey, Matthew; Webb, Angela; Nguyen, Kevin; Hudson, Jo; Chin, Kwang Yang; Cardin, Anthony; Ravi, Rajeev; Morrison, Edwin; Quinn, Tam; Hunt, Ian; Rischin, Danny

Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma

辅助性西米普利单抗治疗高危皮肤鳞状细胞癌的影响

Lim, Annette M; Porceddu, Sandro; Rischin, Danny

Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma

KEYNOTE-412研究中与健康相关的生活质量结果:接受或不接受帕博利珠单抗治疗的头颈部鳞状细胞癌患者的放化疗

Machiels, J-P; Tao, Y; Licitra, L; Burtness, B; Tahara, M; Rischin, D; Alves, G V; Lima, I P F; Hughes, B G M; Pointreau, Y; Aksoy, S; Laban, S; Greil, R; Burian, M; Hetnal, M; Delord, J-P; Mesia, R; Taberna, M; Waldron, J; Simon, C; Gregoire, V; Harrington, K; Black, C M; Norquist, J M; Wang, A; Gumuscu, B; Bidadi, B; Siu, L L

Cemiplimab in the treatment of cutaneous squamous cell carcinoma

Cemiplimab 用于治疗皮肤鳞状细胞癌

McLean, Luke S; Lim, Annette M; Rischin, Danny